Materialise NV Website

Materialise NV

NasdaqGS-MTLS

Company Overview

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

  • Name

    Materialise NV

  • CEO

    Brigitte de Vet-Veithen

  • Website

    www.materialise.com

  • Sector

    Software

  • Year Founded

    1990

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

What's happening

Nov 13, 2025 - Dec 13, 2025

Materialise NV Faces Challenges Despite Positive Corporate Developments

  • Materialise NV held an Extraordinary Shareholders’ Meeting on November 17, where all proposed resolutions were approved, reinforcing its operational structure.
  • The successful launch of Materialise NV on Euronext Brussels on November 20 resulted in a significant stock price increase of 3.3%.
  • Despite positive events, broader economic concerns led to bearish sentiments impacting the overall performance of MTLS.

Over the past month, Materialise NV (MTLS) experienced a decline of 4.0%, significantly underperforming relative to the S&P 500's slight decrease of only 0.2%. This performance gap indicates that MTLS struggled more than broader market trends during this period. Notably, despite this downturn, there were key bullish events that positively influenced investor sentiment.

On November 17, the company conducted an Extraordinary Shareholders’ Meeting where all proposed resolutions received approval. This meeting was crucial as it reinforced the company's operational structure and governance framework while emphasizing its focus on additive manufacturing software and 3D printing solutions across various industries such as healthcare and aerospace. Following this event, investor confidence surged slightly with a modest stock price increase of 1%.

Investor optimism continued with the successful launch of Materialise NV on Euronext Brussels on November 20. This milestone resulted in a notable price increase of approximately 3.3% following announcements regarding voting rights and shares available for trading. These developments are pivotal as they reflect strong governance practices aimed at enhancing investor relations.

However, despite these positive indicators from corporate governance improvements and strategic launches, bearish sentiments persisted throughout much of the month due to macroeconomic factors affecting technology stocks generally. Such conditions likely weighed heavily on MTLS's stock performance as investors remained cautious amid fluctuating market dynamics.

Ultimately, while specific events like shareholder meetings and new listings provided brief moments of optimism for shareholders through temporary increases in stock prices during those instances; they were insufficient to counteract ongoing bearish trends impacting overall monthly performance compared to both sector peers and major indices like S&P 500—resulting in an underperformance margin against S&P by -3.8%. Notably though within its sector context—specifically against Information Technology (XLK)—Materialise NV outperformed by an impressive margin of 47.1%.

NasdaqGS:MTLS